Table 2.
Efficacy analysis of STER in the treatment of submucosal masses in esophageal muscularis propria [cases (%)].
| Groups | Cases | Complete remission | Partial remission | Stability | Deterioration | Effective rate |
|---|---|---|---|---|---|---|
| The STER group | 136 | 56 (41.18) | 70 (51.47) | 8 (5.88) | 2 (1.47) | 134 (98.53) |
| The ESD group | 136 | 49 (36.03) | 59 (43.38) | 13 (9.56) | 15 (11.03) | 121 (88.97) |
| χ 2 | 0.760 | 1.784 | 1.290 | 10.604 | 10.604 | |
| P | 0.383 | 0.182 | 0.256 | 0.001 | 0.001 |